Windlas Biotech Q4 Results
- BSE: 543329
- NSE: WINDLAS
- ISIN: INE0H5O01029
- Sector: Biotechnology & Drugs
BSE
947.95
-44.60 (-4.49%)
-44.60 (-4.49%)Volume9.27 K
Updated: Fri 9 Oct, 2026 | 15:57:33
NSE
949.20-42.40 (-4.28%)
-42.40 (-4.28%)Volume1.29 L
Updated: Fri 9 Oct, 2026 | 15:31:46
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Windlas Biotech Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 221.21 | 216.42 | 2.21% | 152.82 | 19.26% |
| Depreciation/ Amortization | 8.00 | 7.70 | 3.90% | 3.54 | -4.03% |
| Operating Income | 17.29 | 16.68 | 3.65% | 18.47 | 0.42% |
| Net Income | 15.99 | 15.00 | 6.59% | 16.99 | -1.79% |
| Other Operating Expenses Total | 24.79 | 23.18 | 6.98% | 19.28 | 23.73% |
| Net Income Before Taxes | 20.16 | 19.97 | 0.95% | 22.63 | -3.18% |
| Total Revenue | 238.50 | 233.10 | 2.32% | 171.29 | 17.66% |
| Selling/ General/ Admin Expenses Total | 41.37 | 42.05 | -1.61% | 22.85 | 29.57% |
| Diluted Normalized EPS | 7.39 | 7.05 | 4.80% | 8.07 | -3.63% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.